# Study to Evaluate the Effectiveness, Safety and Long Term Safety of Saypha® FILLER Lidocaine for Lip Augmentation

> **NCT04917588** · NA · COMPLETED · sponsor: **Croma-Pharma GmbH** · enrollment: 114 (actual)

## Conditions studied

- Abnormal Lip

## Interventions

- **COMBINATION_PRODUCT:** Saypha® FILLER Lidocaine (HQ)
- **COMBINATION_PRODUCT:** Saypha® FILLER Lidocaine (C1)

## Key facts

- **NCT ID:** NCT04917588
- **Lead sponsor:** Croma-Pharma GmbH
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-07-28
- **Primary completion:** 2020-12-14
- **Final completion:** 2022-04-06
- **Target enrollment:** 114 (ACTUAL)
- **Last updated:** 2025-03-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04917588

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04917588, "Study to Evaluate the Effectiveness, Safety and Long Term Safety of Saypha® FILLER Lidocaine for Lip Augmentation". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT04917588. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*